Annual Cash & Cash Equivalents:
$84.38M-$72.64M(-46.26%)Summary
- As of today, IDYA annual cash & cash equivalents is $84.38 million, with the most recent change of -$72.64 million (-46.26%) on December 31, 2024.
- During the last 3 years, IDYA annual cash & cash equivalents has fallen by -$7.67 million (-8.33%).
- IDYA annual cash & cash equivalents is now -46.26% below its all-time high of $157.02 million, reached on December 31, 2023.
Performance
IDYA Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$669.74M-$22.77M(-3.29%)Summary
- As of today, IDYA quarterly cash & cash equivalents is $669.74 million, with the most recent change of -$22.77 million (-3.29%) on June 30, 2025.
- Over the past year, IDYA quarterly cash & cash equivalents has dropped by -$31.92 million (-4.55%).
- IDYA quarterly cash & cash equivalents is now -27.20% below its all-time high of $920.03 million, reached on September 30, 2024.
Performance
IDYA Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IDYA Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -46.3% | -4.5% |
| 3Y3 Years | -8.3% | +149.3% |
| 5Y5 Years | +147.7% | +293.0% |
IDYA Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -46.3% | +22.9% | -27.2% | +97.3% |
| 5Y | 5-Year | -46.3% | +147.7% | -27.2% | +171.4% |
| All-Time | All-Time | -46.3% | +1315.5% | -27.2% | +3166.2% |
IDYA Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $669.74M(-3.3%) |
| Mar 2025 | - | $692.51M(+2.4%) |
| Dec 2024 | $84.38M(-46.3%) | $676.32M(-26.5%) |
| Sep 2024 | - | $920.03M(+31.1%) |
| Jun 2024 | - | $701.66M(+0.4%) |
| Mar 2024 | - | $698.77M(+33.1%) |
| Dec 2023 | $157.02M(+128.8%) | $525.11M(+12.0%) |
| Sep 2023 | - | $468.75M(-5.1%) |
| Jun 2023 | - | $493.72M(+45.4%) |
| Mar 2023 | - | $339.47M(-7.0%) |
| Dec 2022 | $68.63M(-25.4%) | $364.83M(-5.5%) |
| Sep 2022 | - | $386.24M(+43.8%) |
| Jun 2022 | - | $268.62M(+6.3%) |
| Mar 2022 | - | $252.60M(+2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $92.05M(+27.8%) | $246.77M(-6.7%) |
| Sep 2021 | - | $264.55M(-3.5%) |
| Jun 2021 | - | $274.18M(-9.3%) |
| Mar 2021 | - | $302.32M(+6.6%) |
| Dec 2020 | $72.04M(+111.5%) | $283.58M(+1.8%) |
| Sep 2020 | - | $278.68M(+63.5%) |
| Jun 2020 | - | $170.41M(+94.0%) |
| Mar 2020 | - | $87.86M(-11.2%) |
| Dec 2019 | $34.07M(+66.1%) | $98.96M(-9.5%) |
| Sep 2019 | - | $109.36M(-9.0%) |
| Jun 2019 | - | $120.16M(+52.1%) |
| Mar 2019 | - | $79.02M(+285.4%) |
| Dec 2018 | $20.50M(+244.0%) | $20.50M |
| Dec 2017 | $5.96M | - |
FAQ
- What is IDEAYA Biosciences, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for IDEAYA Biosciences, Inc.?
- What is IDEAYA Biosciences, Inc. annual cash & cash equivalents year-on-year change?
- What is IDEAYA Biosciences, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for IDEAYA Biosciences, Inc.?
- What is IDEAYA Biosciences, Inc. quarterly cash & cash equivalents year-on-year change?
What is IDEAYA Biosciences, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of IDYA is $84.38M
What is the all-time high annual cash & cash equivalents for IDEAYA Biosciences, Inc.?
IDEAYA Biosciences, Inc. all-time high annual cash & cash equivalents is $157.02M
What is IDEAYA Biosciences, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, IDYA annual cash & cash equivalents has changed by -$72.64M (-46.26%)
What is IDEAYA Biosciences, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of IDYA is $669.74M
What is the all-time high quarterly cash & cash equivalents for IDEAYA Biosciences, Inc.?
IDEAYA Biosciences, Inc. all-time high quarterly cash & cash equivalents is $920.03M
What is IDEAYA Biosciences, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, IDYA quarterly cash & cash equivalents has changed by -$31.92M (-4.55%)